Skip to content

Effects of optimized orthokeratology on prevention and control of myopia

Analysis on prevention and control effect of deviation of orthokeratology and related influencing factors

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059009
Enrollment
Unknown
Registered
2022-04-22
Start date
2022-04-15
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

orthokeratology deviation group:None

Sponsors

Qingdao Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. After mydriatic optometry, the bulb degree was -0.50D~-8.0D, and the column degree was < -2.00D; 2. Patients aged 8 to 18 years; 3. Optimal corrected visual acuity of 1.0 or above; 4. Patients need to sign informed consent voluntarily; 5. Patients should be able and willing to follow up on time during the study period.

Exclusion criteria

Exclusion criteria: 1. The patient has underlying, recurrent or progressive corneal disease, corneal abnormalities (especially recurrent corneal erosion, severe stromal lesions, keratoconus, marginal hyaline corneal degeneration); 2. The patient has irregular corneal morphology in one or both eyes; 3. The patient is taking some systemic drugs that may affect diopter, such as adrenocorticosteroids and antimetabolites; 4. Patients with immune insufficiency or connective tissue disease, dominant genetic disease or diabetes; 5. The patient had a history of eye surgery; 6. The patient had irregular central corneal curvature; 7. Patients are allergic to the drugs used in the study; 8. The patient has a history of glaucoma or suspected glaucoma; 9. The patient participated in other trials during the trial; 10. The patient has a history of herpetic keratitis; 11. Patients use topical or systemic drugs to control myopia progression; 12. The patient suffers from nystagmus or cannot fixate for a long time during surgery; 13. The patient has poor ocular surface conditions (such as severe dry eyes, blepharitis, meibomian gland dysfunction, allergic conjunctivitis, etc.).

Design outcomes

Primary

MeasureTime frame
axial length;wavefront aberration;visual quality;peripheral retina defocus;corneal biomechanics;visual acuity;refraction;keratometry;

Countries

China

Contacts

Public ContactLeng Lin

Qingdao Eye Hospital of Shandong First Medical University

coollin.1987@163.com+86 18661800680

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026